ATE440836T1 - Verbindungen - Google Patents

Verbindungen

Info

Publication number
ATE440836T1
ATE440836T1 AT06791540T AT06791540T ATE440836T1 AT E440836 T1 ATE440836 T1 AT E440836T1 AT 06791540 T AT06791540 T AT 06791540T AT 06791540 T AT06791540 T AT 06791540T AT E440836 T1 ATE440836 T1 AT E440836T1
Authority
AT
Austria
Prior art keywords
links
salts
compounds
processes
formula
Prior art date
Application number
AT06791540T
Other languages
English (en)
Inventor
Rachael Ancliff
Mark Bamford
Simon Hodgson
Christopher Parr
Panayiotis Procopiou
David Wilson
Michael Woodrow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE440836T1 publication Critical patent/ATE440836T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Liquid Crystal (AREA)
AT06791540T 2005-07-19 2006-07-17 Verbindungen ATE440836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0514811.9A GB0514811D0 (en) 2005-07-19 2005-07-19 Compounds
PCT/EP2006/007034 WO2007009739A1 (en) 2005-07-19 2006-07-17 Compounds

Publications (1)

Publication Number Publication Date
ATE440836T1 true ATE440836T1 (de) 2009-09-15

Family

ID=34897469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06791540T ATE440836T1 (de) 2005-07-19 2006-07-17 Verbindungen

Country Status (8)

Country Link
US (1) US20080207638A1 (de)
EP (1) EP1904484B1 (de)
JP (1) JP2009501744A (de)
AT (1) ATE440836T1 (de)
DE (1) DE602006008788D1 (de)
ES (1) ES2330472T3 (de)
GB (1) GB0514811D0 (de)
WO (1) WO2007009739A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010005225A (es) * 2007-11-13 2010-05-27 Taisho Pharmaceutical Co Ltd Derivados de fenilpirazol.
CN102137858B (zh) 2008-05-23 2014-07-23 潘米拉制药有限责任公司 5-脂氧合酶-活化蛋白抑制剂
JP5740838B2 (ja) * 2009-05-12 2015-07-01 大正製薬株式会社 フェニルピラゾール誘導体
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
JP6110611B2 (ja) * 2012-07-18 2017-04-05 株式会社東芝 アミンの回収方法および分析方法
WO2015173701A2 (en) 2014-05-12 2015-11-19 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions for treating infectious diseases
BR112022019245A2 (pt) 2020-03-26 2022-11-16 Glaxosmithkline Ip Dev Ltd Inibidores de catepsina para prevenir ou tratar infecções virais

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19614204A1 (de) * 1996-04-10 1997-10-16 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
JP4516717B2 (ja) * 2000-07-13 2010-08-04 アボット・ラボラトリーズ ヒスタミン−3受容体リガンドとしての1,3−二置換ピロリジン及び1,3,3−三置換ピロリジン並びにそれらの治療的応用
GB0224084D0 (en) * 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0514812D0 (en) * 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
JP2009501744A (ja) 2009-01-22
WO2007009739A1 (en) 2007-01-25
EP1904484A1 (de) 2008-04-02
ES2330472T3 (es) 2009-12-10
EP1904484B1 (de) 2009-08-26
DE602006008788D1 (de) 2009-10-08
GB0514811D0 (en) 2005-08-24
US20080207638A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
EA201001821A1 (ru) Производные триазола, полезные для лечения заболеваний
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
EA200870282A1 (ru) Производные амина
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
EA201100503A1 (ru) Глюкозидные производные и их применения
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
EA200601223A1 (ru) Производные сульфонамида для лечения заболеваний
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA200601391A1 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
WO2006100081A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
TW200738659A (en) Novel compounds
WO2008074803A8 (en) 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
DE602007004327D1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
DE602006008788D1 (de) Verbindungen
TW200745081A (en) Compounds
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties